Interesting facts
Interesting Facts about 1-[2-hydroxy-3-propyl-4-[4-(2H-tetrazol-5-yl)butoxy]phenyl]ethanone
This compound, characterized by its complex structure, is a fascinating example of how organic chemistry continues to innovate through unique functionalities and modifications.
Key Features
- Hydroxy Group: The presence of a hydroxy group in the molecule suggests potential for hydrogen bonding, which may enhance its solubility and reactivity in biological systems.
- Tetrazole Integration: The incorporation of a tetrazole ring greatly contributes to the compound's biological activity, particularly in pharmaceuticals where tetrazoles are often found in antihypertensive and anti-inflammatory agents.
- Multifunctionality: The structure includes several functional groups that lend themselves to diverse applications, ranging from material sciences to medicinal chemistry.
Potential Applications
The intricate design of this compound opens various pathways for research and usage. Here are a few potential applications:
- Medicinal chemistry for developing new therapeutic agents.
- As a chemical probe in biochemistry for exploring interactions with biological targets.
- Possibly utilized in the synthesis of advanced materials due to its unique electronic properties.
Quote from the Lab
One researcher noted, "The integration of tetrazole rings into organic compounds can lead to unprecedented interactions in biological systems, enhancing both efficacy and specificity."
This compound exemplifies how intricate organic compounds can provide valuable insights into both fundamental chemistry and practical applications. Its status as a part of ongoing research demonstrates the ever-evolving nature of chemical exploration and innovation.
Synonyms
Tomelukast
88107-10-2
LY 171883
LY-171883
LY171883
Tomelukastum
Tomelukastum [INN-Latin]
Tomelukast [USAN:INN]
Lilly 171883
Compound LY171883
Ethanone,1-[2-hydroxy-3-propyl-4-[4-(2H-tetrazol-5-yl)butoxy]phenyl]-
BRN 4238438
ETHANONE, 1-(2-HYDROXY-3-PROPYL-4-(4-(1H-TETRAZOL-5-YL)BUTOXY)PHENYL)-
DTXSID7020344
CHEBI:75310
59762X5CLS
TOMELUKAST [INN]
TOMELUKAST [USAN]
TOMELUKAST [MART.]
1-[2-Hydroxy-3-propyl-4-[4-(1H-tetrazol-5-yl)butoxy]phenyl]ethanone
1-{2-hydroxy-3-propyl-4-[4-(1H-tetrazol-5-yl)butoxy]phenyl}ethanone
2'-Hydroxy-3'-propyl-4'-(4-(1H-tetrazol-5-yl)butoxy)acetophenone
DTXCID30344
LY-171833
MLS000069512
CHEMBL162358
1-((2-hydroxy-3-propyl)-4-(1H-tetrazol-5-yl)butoxyphenyl)ethanone
1-(2-Hydroxy-3-propyl-4-(4-(1H-tetrazol-5-yl)butoxy)phenyl)ethanone
Acetophenone, 2'-hydroxy-3'-propyl-4-(4-(1H-tetrazol-5-yl)butoxy)-
NCGC00018122-08
SMR000058555
Tomelukastum (INN-Latin)
TOMELUKAST (MART.)
1-(4-(4-(1H-tetrazol-5-yl)butoxy)-2-hydroxy-3-propylphenyl)ethanone
CAS-88107-10-2
SR-05000000448
UNII-59762X5CLS
CPD000058555
Opera_ID_1639
Spectrum3_001918
Spectrum5_001969
Spectrum5_002024
Tomelukast (USAN/INN)
SCHEMBL3944
CBiol_001912
BSPBio_001402
BSPBio_003516
KBioGR_000122
KBioSS_000122
MLS000758272
MLS001423988
BML2-G05
KBio2_000122
KBio2_002690
KBio2_005258
KBio3_000243
KBio3_000244
KBio3_003021
MWYHLEQJTQJHSS-UHFFFAOYSA-N
Bio1_000198
Bio1_000687
Bio1_001176
Bio2_000122
Bio2_000602
HMS1361G04
HMS1791G04
HMS1989G04
HMS2051G21
HMS2231F04
HMS3370J11
HMS3393G21
HMS3402G04
HMS3649C06
5-[4-(4-Acetyl-3-hydroxy-2-propylphenoxy)butyl]-1H-tetrazole
Tox21_110828
Tox21_302412
1-[2-hydroxy-3-propyl-4-[4-(2H-tetrazol-5-yl)butoxy]phenyl]ethanone
5-[4-(1-ACETYL-2-HYDROXY-3-PROPYLPHENOXY)BUTYL]-1H-TETRAZOLE
BDBM50006816
MFCD00211057
1-(2-hydroxy-3-propyl-4-{[4-(1H-tetrazol-5-yl)butyl]oxy}phenyl)ethanone
Tox21_110828_1
CCG-100826
NC00076
1-{2-hydroxy-3-propyl-4-[4-(1H-1,2,3,4-tetrazol-5-yl)butoxy]phenyl}ethanone
IDI1_033872
NCGC00018122-01
NCGC00018122-02
NCGC00018122-03
NCGC00018122-04
NCGC00018122-05
NCGC00018122-06
NCGC00018122-07
NCGC00018122-09
NCGC00018122-10
NCGC00018122-11
NCGC00022570-03
NCGC00022570-04
NCGC00022570-05
NCGC00022570-06
NCGC00022570-07
NCGC00022570-08
NCGC00255249-01
DA-65127
HY-111212
CS-0034652
LY-171,883
NS00123622
D02851
LY-171,883, >=98% (TLC)
SR-05000000448-2
SR-05000000448-3
BRD-K74765201-001-01-9
BRD-K74765201-001-03-5
BRD-K74765201-001-16-7
Q27145209
5-[4-(4-Acetyl-3-hydroxy-2-propylphenoxy)butyl]-tetrazole
5-[4-(4-Acetyl-3-hydroxy-2-propylphenoxy)-butyl]-tetrazole
1-{2-Hydroxy-3-propyl-4-[4-(1H-tetrazol-5-yl)-butoxy]-phenyl}-ethanone
1-{2-Hydroxy-3-propyl-4-[4-(2H-tetrazol-5-yl)-butoxy]-phenyl}-ethanone
(LY-171883)1-{2-Hydroxy-3-propyl-4-[4-(1H-tetrazol-5-yl)-butoxy]-phenyl}-ethanone
1-{2-Hydroxy-3-propyl-4-[4-(1H-tetrazol-5-yl)-butoxy]-phenyl}-ethanone ( LY-171883)
1-{2-Hydroxy-3-propyl-4-[4-(1H-tetrazol-5-yl)-butoxy]-phenyl}-ethanone(LY 171,883)
1-{2-Hydroxy-3-propyl-4-[4-(1H-tetrazol-5-yl)-butoxy]-phenyl}-ethanone(LY-171883)
1-{2-Hydroxy-3-propyl-4-[4-(1H-tetrazol-5-yl)-butoxy]-phenyl}-ethanone(LY171883)
635-828-7
Solubility of 1-[2-hydroxy-3-propyl-4-[4-(2H-tetrazol-5-yl)butoxy]phenyl]ethanone (C29H30N6O6)
The solubility of 1-[2-hydroxy-3-propyl-4-[4-(2H-tetrazol-5-yl)butoxy]phenyl]ethanone is an intriguing aspect of its characterization, particularly given its complex molecular structure. The solubility characteristics can often be influenced by various factors:
In scenarios where solubility is low, micellar solubilization or the use of co-solvents might be considered to enhance the dissolving process. Ultimately, while predicting the solubility of such a multifaceted compound requires detailed experimental data, it is expected that the balance of hydrophilic and hydrophobic components will define its solubility in various solvents.